Polycaprolactone solution–based ink for designing microfluidic channels on paper via 3D printing platform for biosensing application

This work reports a novel fabrication technique for development of channels on paper‐based microfluidic devices using the syringe module of a 3D printing syringe–based system. In this study, printing using polycaprolactone (PCL)‐based ink (Mw 70 000‐90 000) was employed for the generation of functional hydrophobic barriers on Whatman qualitative filter paper grade 1 (approximate thickness of 180 μm and pore diameter of 11 μm), which would effectively channelize fluid flow to multiple assay zones dedicated for different analyte detection on a microfluidic paper‐based analytical device (μPAD). The standardization studies reveal that a functional hydrophilic channel for sample conduction fabricated using the reported technique can be as narrow as 460.7 ± 20 μm and a functional hydrophobic barrier can be of any width with a lower limit of about 982.2 ± 142.75 μm when a minimum number of two layers of the ink is extruded onto paper. A comparison with the hydrodynamic model established for writing with ink is used to explain the width of the line printed by this system. A fluid flow analysis through a single channel system was also carried out to establish its conformity with the Washburn model, which governs the fluid flow in two‐dimensional μPAD. The presented fabrication technique proves to be a robust strategy that effectively taps the advantages of this 3D printing technique in the production of μPADs with enhanced speed and reproducibility.     

Synthesis,characterization, and mechanical properties of PMMA/poly(aromatic/aliphatic siloxane) semi-interpenetrating polymer networks

Semi-interpenetrating polymer networks (IPNs) composed of poly(methyl methacrylate) (PMMA) and aromatic/aliphatic siloxanes have been made via sequential and simultaneous polymerizations. As the percentage of aliphatic siloxane increases, flexibility and, in general, toughness of the IPNs increases and clarity is reduced. This loss in clarity is due to the mismatch of refractive indices (1.49 form PMMA vs. 1.43 for aliphatic siloxane). PMMA is quite transparent. On the other hand, in making aromatic siloxane/PMMA IPNs clarity is retained as aromatic siloxane is increased due to better matching refractive index (1.49 for PMMA and −1.49 for poly(diphenyl siloxane)). Gel permeation chromatography (GPC) indicates slightly crosslinked IPNs with the THF soluble portions having number-average molecular weight, M¯_n, of 10⁵–10⁶. NMRs of IPNs essentially show peaks for the components, PMMA and the siloxane, which make up the respective IPNs. ²⁹Si-NMRs indicate cross-linking and grafting. Mechanical properties show increased toughness of IPNs versus PMMA as percentage of siloxane and crosslinker increases, but with a corresponding loss in tensile strength. © 1996 John Wiley & Sons, Inc.     

Analysis of Organotin Compounds via a Thermabeam® LC–MS Interface

Selected organotin compounds, relating to antifouling paints, have been analysed using a particle beam interface system designed for use on liquid chromatography–mass spectrometry (LC–MS) instruments. The resultant mass spectra matched those obtained from conventional electron-impact (EI) techniques, and consistent data over several injections and different elution times were obtained. Data obtained from tributyltin, dibutyltin, monobutyltin, triphenyltin and diphenyltin (each as the chlorides) are presented. This interface has been shown to maintain sample and therefore spectral integrity for these compounds and is of potential use in further investigations relating to organotin environmental pollution.     

Recent advances in the neodymium catalysed polymerisation of 1,3-dienes

The benefits of using a homogeneous neodymium-based catalyst for the industrial “high cis” polymerisation of 1,3-butadiene are underlined. Preformed homogeneous catalysts for the “high cis” polymerisation of 1,3-butadiene based on Nd(carboxylate)₃/diisobutylaluminium hydride/^tbutyl chloride have been examined. The effects of changing (a) the order of catalyst component addition, (b) the carboxylate component and (c) the halogen component, on catalyst homogeneity, activity and polymer characteristics have been examined.     

Column selectivity in reversed-phase liquid chromatography. VI. Columns with embedded or end-capping polar groups

A previous model of column selectivity for reversed-phase liquid chromatography (RP-LC) has been applied to an additional 21 columns with embedded or end-capping polar groups (EPGs). Embedded-polar-group columns exhibit a significantly different selectivity vs. non-EPG, type-B columns, generally showing preferential retention of hydrogen-bond donors, as well as decreased retention for hydrogen-bond acceptors or ionized bases. EPG-columns are also generally less hydrophobic (more polar) than are non-EPG-columns. Interestingly, columns with polar end-capping tend to more closely resemble non-EPG columns, suggesting that the polar group has less effect on column selectivity when used to end-cap the column versus the case of an embedded polar group. Column selectivity data reported here for EPG-columns can be combined with previously reported values for non-EPG columns to provide a database of 154 different columns. This enables a comparison of any two of these columns in terms of selectivity. However, comparisons that involve EPG columns are more approximate.     

Crosslinked penicillin acylase aggregates for synthesis of β-lactam antibiotics in organic medium

Crosslinked enzyme aggregates (CLEAs) of a partially purified penicillin acylase from a recombinant Escherichia coli strain have been produced as a novel type of biocatalysts well endowed to perform in organic media. Different protein precipitants were studied and glutaraldehyde was used as the crosslinking agent. Precipitation curves were obtained for all precipitants to determine the concentrations at which all the protein precipitated out of the solution. The effect of the glutaraldehyde-to-protein ratio was studied with respect to process recovery and the specific activity and stability of the biocatalyst. Recovery of penicillin acylase activity was moderately high, about 50%; major losses of enzyme activity were produced at the precipitation step. Specific activities of all CLEAs were very high, which is one of the advantages of using nonsupported biocatalysts. Ammonium sulfate and tert-butyl alcohol were the best precipitants at a glutaraldehyde-protein mass ratio of 2 and were selected to perform the kinetically controlled synthesis of ampicillin in 60% (v/v) ethylene glycol medium. At comparable conversion yields, volumetric and specific antibiotic productivity were much higher for CLEAs than for carrier-bound penicillin acylases.     

Synthesis and solid-state structural characterisation of Pt(II,IV) bromide complexes containing bidentate organothiomethylpyridine heteroleptic ligands

A convenient synthetic method for the preparation of organothiomethylpyridine ligands 2-(RSCH₂)C₅H₄N (R = Ph (L¹), Me (L²)), 2-MeS–6-Me-C₅H₃N (L³), and 2-MeS–4-Me-C₅H₃N (L⁴) via the initial lithiation of substituted 2-picolines followed by the nucleophilic reaction with a diorganyldisulfide is described. The complexes [PtBr₂L] (L = L¹–L⁴) have been prepared in good to high yields as yellow solids with low solubility in organic solvents. The solid state structures of the complexes have been determined, showing the spatial arrangement of the complexes to depend significantly upon varying substituents within the ligand. The complexes undergo oxidation by bromine to form the tetravalent complexes [PtBr₄(L)] (L = L¹–L⁴). The solid state structures of [PtBr₄(L²)] and [PtBr₄(L₄)] have been determined, and shown to be monomeric with the ligand chelating the platinum centre.     

Chemical Proteomics and Phenotypic Profiling Identifies the Aryl Hydrocarbon Receptor as a Molecular Target of the Utrophin Modulator Ezutromid

Duchenne muscular dystrophy (DMD) is a fatal muscle‐wasting disease arising from mutations in the dystrophin gene. Upregulation of utrophin to compensate for the missing dystrophin offers a potential therapy independent of patient genotype. The first‐in‐class utrophin modulator ezutromid/SMT C1100 was developed from a phenotypic screen through to a Phase 2 clinical trial. Promising efficacy and evidence of target engagement was observed in DMD patients after 24 weeks of treatment, however trial endpoints were not met after 48 weeks. The objective of this study was to understand the mechanism of action of ezutromid which could explain the lack of sustained efficacy and help development of new generations of utrophin modulators. Using chemical proteomics and phenotypic profiling we show that the aryl hydrocarbon receptor (AhR) is a target of ezutromid. Several lines of evidence demonstrate that ezutromid binds AhR with an apparent K_D of 50 nm  and behaves as an AhR antagonist. Furthermore, other reported AhR antagonists also upregulate utrophin, showing that this pathway, which is currently being explored in other clinical applications including oncology and rheumatoid arthritis, could also be exploited in future DMD therapies.